Evidence map›Paper›PMID 36203559›Full record

ArticleFrontiers in immunology2022

High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation.

Hirofumi Kashiwagi, Toshiro Seki, Shino Oshima, Yusuke Ohno, Tomoka Shimizu, Soga Yamada, Nagi Katano, Yumiko Goto, Atsushi Yasuda, Banri Tsuda and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Sex Steroid Hormone Regulation of T-Cell Function and Antitumor Immunity.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Hirofumi KashiwagiDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
Toshiro SekiDepartment of Internal Medicine, Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Shino OshimaDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Yusuke OhnoDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Tomoka ShimizuDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Soga YamadaDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Nagi KatanoDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Yumiko GotoDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
Atsushi YasudaDepartment of Internal Medicine, Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Banri TsudaDepartment of Palliative Medicine, Tokai University School of Medicine, Isehara, Japan.
Ryoji ItoCentral Institute for Experimental Animals, Kawasaki, Japan.
Shun-Ichiro IzumiDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
Hitoshi IshimotoDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan.
Takashi ShiinaDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Yoshie KametaniDepartment of Molecular Life Science, Division of Basic Medical Science, Tokai University School of Medicine, Isehara, Japan.
Tokai University · JPCentral Institute for Experimental Animals · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progesterone (P4) and glucocorticoid (GC) play crucial roles in the immunoregulation of a mother to accept and maintain a semi-allogenic fetus. P4 concentration increases during pregnancy and becomes much higher in the placenta than in the other peripheral tissues, wherein the concentration of cortisol (COR), the most abundant GC and a strong immunosuppressor, remains uniform throughout the rest of the body. Here, we evaluated the effect of a high-P4 environment on pregnant immunity by comparing it with COR. Naïve T cell proportion increased transiently in peripheral blood of pregnant women just after delivery and decreased after one month. T cells stimulated with superantigen toxic-shock-syndrome-1 (TSST-1) in the presence of P4 stayed in the naïve state and did not increase, irrespective of the presence of COR, and reactive T cells could not survive. Treatment of T cells with P4 without T cell receptor (TCR) stimulation transiently suppressed T cell activation and proliferation, whereas the levels remain unaltered if P4 was not given before stimulation. Comparison of the engraftment and response against specific antigens using hu-PBL-NOG-hIL-4-Tg mice showed that P4-pretreated lymphocytes preserved CD62L expression and engrafted effectively in the spleen. Moreover, they produced antigen-specific antibodies, whereas COR-pretreated lymphocytes did not. These results suggest that a high-P4 environment suppresses T cell activation and induces T cell migration into lymphoid tissues, where they maintain the ability to produce anti-pathogen antibodies, whereas COR does not preserve T cell function. The mechanism may be pivotal in maintaining non-fetus-specific T cell function in pregnancy.

Indexed as

ProgesteroneT-LymphocytesAnimalsFemaleGlucocorticoidsHumansHydrocortisoneLymphocyte ActivationMicePregnancyReceptors, Antigen, T-CellSuperantigensGlucocorticoidsHydrocortisoneProgesteroneReceptors, Antigen, T-CellSuperantigensCD62Lcortisolhumanized mousepregnant immunityprogesteronespecific antibodyT celltoxic shock syndrome toxin-1

Identifiers

PMID36203559
PMCPMC9530059
OpenAlexW4297905878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.